Dr. Kalemkerian completed medical school, internal medicine residency and one year of chief residency at Northwestern University in Chicago. He then completed a clinical and research fellowship in Medical Oncology at the Johns Hopkins Oncology Center in Baltimore. From 1993-1999, he was a physician-scientist in the Lung Cancer Program at the Karmanos Cancer Institute at Wayne State University in Detroit, where his research focused on the development of novel therapeutic strategies for lung cancer.
Since coming to the University of Michigan in 1999, Dr. Kalemkerian has continued to care for patients with lung cancer, thymoma and mesothelioma. He also directs the Multidisciplinary Lung Cancer Team and performs clinical research with a focus on investigational treatments for lung cancer. He has been the Principal Investigator for numerous clinical trials based on laboratory research and continues to develop novel therapies for patients with lung cancer and other thoracic cancers. The ultimate goal of his clinical and research work is to improve the lives of people with thoracic malignancies.
In addition to his clinical and research activities, Dr. Kalemkerian is the Chair of the NCCN Small Cell Lung Cancer Guidelines Panel and has been consistently recognized by his peers through selection to Best Doctors in America since 2003. He has served on numerous grant review committees, Editorial Boards, and committees of the American Society of Clinical Oncology and the International Association for the Study of Lung Cancer. He has authored over 150 original research publications, review articles, editorials, and book chapters, and has edited two textbooks on lung cancer.